Lv5
1450 积分 2026-03-21 加入
Long-acting oral weekly risperidone (LYN-005) for schizophrenia in the USA (STARLYNG-1): a multicentre, open-label, non-randomised phase 3 trial
13天前
已完结
Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials
26天前
已完结
Injectable long-acting formulations (ILAFs) and manufacturing techniques
26天前
已完结
The coming of age of cyclic peptide drugs: an update on discovery technologies
29天前
已完结
Long-acting oral weekly risperidone (LYN-005) for schizophrenia in the USA (STARLYNG-1): a multicentre, open-label, non-randomised phase 3 trial
1个月前
已完结
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor
1个月前
已完结
Analysis of molecular weight of mixed poly (lactide-co-glycolide) in Risperidone microspheres based on separation method
1个月前
已完结
Development of in vitro/in vivo correlation for long-acting injectable suspensions via bootstrapping
1个月前
已完结
Dissolving Microneedle Patch Integrated with Microspheres for Long-Acting Hair Regrowth Therapy
1个月前
已完结
Stage-adaptive nanotherapeutic design for blood–brain barrier navigation in ischemic stroke
2个月前
已关闭
皖公网安备34019202002308
